Linge, J., Nasr, P., Sanyal, A. J., Dahlqvist Leinhard, O., and Ekstedt, M. (2022) Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD, JHEP Reports, doi: 10.1016/j.jhepr.2022.100663
Cardiometabolic health improvements upon dietary intervention are driven by tissue-specific insulin resistance phenotype: A precision nutrition trial
Inez Trouwborst, Anouk Gijbels, Kelly M. Jardon, Els Siebelink, Gabby B. Hul, Lisa Wanders, Balázs Erdos, Szabolcs Péter, Cécile M. Singh-Povel, Johan de Vogel-van den Bosch, Michiel E. Adriaens, Ilja C.W. Arts, Dick H.J. Thijssen, Edith J.M. Feskens, Gijs H. Goossens, Lydia A. Afman, and Ellen E. Blaak
Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI: Composite Scores for Longitudinal and Cross-Sectional Analysis
Mellion, M. L., Widholm, P., Karlsson, M., Ahlgren, A., Tawil, R., Wagner, K. R., Statland, J. M., Wang, L., Shieh, P. B., Engelen v., B., G.M., Kools, J., Ronco, L., Odueyungbo, A., Jiang, J., Han, J., J., Hatch, M., Towles, J., Leinhard, D., O., Cadavid, D. (2022) Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI: Composite Scores for Longitudinal and Cross-Sectional Analysis. Neurology, Jun 2022; doi: 10.1212/WNL.0000000000200757
Quantitative Muscle Analysis in Facioscapulohumeral Muscular Dystrophy Using Whole-Body Fat-Referenced MRI: Protocol Development, Multicenter Feasibility, and Repeatability
Widholm P, Ahlgren A, Karlsson M, Romu T, Tawil R, Wagner KR, Statland JM, Wang LH, Shieh PB, van Engelen BGM, Cadavid D, Ronco L, Odueyungbo AO, Jiang JG, Mellion ML, Leinhard OD. Quantitative Muscle Analysis in Facioscapulohumeral Muscular Dystrophy Using Whole-Body Fat-Referenced MRI: Protocol Development, Multicenter Feasibility, and Repeatability. Muscle Nerve. 2022 May 18. doi: 10.1002/mus.27638.
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
Gastaldelli, A., Cusi, K., Fernández Landó, L., Bray, R., Brouwers, B., Rodríguez, Á. Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial. The Lancet Diabetes & Endocrinology, 2022, ISSN 2213-8587, https://doi.org/10.1016/S2213-8587(22)00070-5.
Differential fuel utilization in liver transplant recipients and its relationship with non-alcoholic fatty liver disease
Siddiqui, MS, Patel, S, Forsgren, M, Bui, AT, Shen, S, Syed, T, Boyett, S, Chen, S, Sanyal, AJ, Wolver, S, Kirkman, D, Celi, FS & Bhati, CS . Differential fuel utilization in liver transplant recipients and its relationship with non-alcoholic fatty liver disease. Liver Int. 2022; 00: 1– 9. doi: 10.1111/liv.15178